Le Lézard
Classified in: Health
Subjects: PDT, PLW, MAT

3BP, Inc. Announces Patent Issued for Package Damage Indication


FORT WASHINGTON, Pa., Nov. 5, 2018 /PRNewswire/ -- The newly issued patent for Damage-Indicating PackagingTM allows 3BP, Inc. ("3BP") to move forward with more extensive research and development and further expand its smart packaging product line.  The company, known as 3BPTM is an active and intelligent packaging manufacturing startup with a unique line of packaging for the condom, pharmaceutical, food, and cannabis markets. The patent provides distinct intelligence features that set new standards in package safety.

"3BP is not reinventing the packaging wheel, we've just figured out a way to make it safer," says co-Founder Auguste Jacques.  3BP's Damage-Indicating Packaging is "smart" and designed to automatically identify and act on tampering, contamination, and counterfeiting of packaged and pre-packaged products. The state-of-the-art product packaging quickly identifies contamination by heat, time, and/or air. 3BP's patented damage-indicating, contamination-evident indicators turn a distinctive color that warns the consumer that the product is unfit for its intended use.   The color change is customizable to a manufacturer's needs/request or based on application.

The color changing technology provides a value-added synergy to existing packaging, and can easily and successfully be applied to any of the product packaging currently on the market. The product is cost-effective for manufacturers and distributors and safe for consumers.  Now that the patent has been issued, 3BP is actively working on a new phase of R & D while looking for partnerships and investors.  The next phase of R &D will include more advanced live track and trace packaging. 

About 3BP, Inc.

Originally, the technology was designed for the condom packaging industry. The execution involved the placement of the tamper-evident packaging as an added layer to the interior or exterior of existing condom packaging, thereby preventing the oxygen-indicating dye from coming into direct contact with the condom. The detection of damage to the condom minimizes the risk of unplanned pregnancies and sexually transmitted infections (STIs). The evidence of damage to the condom package with the patented color changing technology arms the user with a visible deterrent, as opposed to the previous standard of an air bubble or an expiration date on the packaging.

Following the formation of Baby Blue, the Founders recognized a much broader application for the growing packaging industry and new demand for packaging safety. As a consequence, the Founders formed a sister entity of Baby Blue - 3BP- to integrate the use of non-condom related active and intelligent packaging ("3B Packaging") across a wide-array of industries with similar application.  Oxygen-indicating ink incorporated into the transparent packaging changes color upon a breach of the packaging. The 3BP packaging provides an outer layer to existing generic or brand-specific packaging thereby eliminating any direct contact with the packaged products. Upon exposure to air, a discernable color change will occur within minutes or days based on the intended use and application. The process provides safety and quality assurance to end users and benefits manufacturers, distributors and retailers by decreasing waste and financial loss due to returned merchandise.

3BPTM Active and Intelligent Packaging's mission is to provide a high quality and well recognizable brand of superior and advanced manufacturing technology that advances ease of use and peace of mind in knowing that a product will work for its intended purpose.

For more information, contact 3BP, Inc. at [email protected].

Media Contact:
Dana Klein
954-665-5962
[email protected] 

SOURCE 3BP, Inc.


These press releases may also interest you

at 02:05
PureTech Health plc ("PureTech" or the "Company") plans to publish its Annual Report and Accounts and financial results for the year ended December 31, 2023, on Thursday, April 25, 2024. A presentation and conference call to discuss the results...

at 02:05
Hansa Biopharma, the pioneer in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced its business update and year-end report for January to March 2024. Highlights for the first quarter of 2024      Strong commercial...

at 01:30
The shares in Aker ASA will be traded ex-dividend NOK 15.50 as from today, 18 April 2024. Investor contact:Fredrik Berge, Head of Investor Relations Aker ASA Tel: +47 450 32 090 E-mail: [email protected] Media contact:Atle Kigen, Head of...

at 00:00
Health Carousel, renowned for its dedication to enhancing the healthcare staffing sector, today unveiled its groundbreaking 'Full Circle of Support' program. This initiative represents a significant investment in the total well-being of its...

17 avr 2024
TaiGen Biotechnology Company, Limited ("TaiGen") announces today that the business partner, Joincare Pharmaceutical, has completed the unblinding of influenza antiviral TG-1000 phase III study. Preliminary data shows that the median time to...

17 avr 2024
SysInformation Healthcare Services, LLC ("SysInformation"), d/b/a EqualizeRCM and 1st Credentialing, is providing notice of a recent data security event that may affect the security of information related to certain individuals. SysInformation is...



News published on and distributed by: